Humana shares tumble as 2025 membership for its top-rated Medicare plans slump

(Reuters) -Humana said on Wednesday that a lower-performance rating for a widely used Medicare insurance plan hurt enrollments for 2025 and will potentially hit the health insurer's revenue and bonus payments in 2026, sending shares down about 23% premarket.

The company said it has about 1.6 million, or 25% of its total members, currently enrolled in the plans rated 4 stars and above for 2025, down from 94% in 2024.

The star rating for a Humana (NYSE:HUM ) contract, which accounts for about 45% of its Medicare Advantage memberships, dipped to 3.5 in 2025 from 4.5 a year earlier, according to preliminary data released by the Centers for Medicare & Medicaid Services on Tuesday.

Humana said the reduction in star ratings was driven by narrowly missing higher industry cut points on a small number of measures, and it was the reason for the decline in enrollment for its top-rated plans for 2025.

The star ratings, on a scale of 5, determine the reimbursement levels and can sway enrollees in choosing plans.

Shares of the company, which have fallen nearly 39% so far this year, slipped to $208.10 before the bell on Tuesday.

"Humana is exploring all available options to mitigate the expected 2026 revenue headwind related to its 2025 Star ratings," the company said.

The decline in star rating for 2025 will impact Humana's quality bonus payments in 2026, the company said.

Humana said it believes "there may be potential errors" in the federal agency's calculation of some results and industry wide points.

It said appeals to certain results are pending, and Humana has requested additional information from the agency.



Health insurers, which offer Medicare Advantage plans, are paid a set rate by the government to manage healthcare for people aged 65 and older or with disabilities.

Star rating details for 2025 are expected to be formally released by the agency on or around Oct. 10.

Source: Investing.com

Останні публікації
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Аналіз ринку Як вплине завтра звіт NFP на курс долара США?